Oxido-reductive state: The major determinant for cellular retention of technetium-99m-HMPAO

Journal of Nuclear Medicine

Volumn 37, Issue 8, 1996, Pages 1413-1416

  Jacquier Sarlin, M R ^b   Polla, B S ^b   Slosman, D O ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

brain perfusion; cellular uptake; technetium 99m HMPAO

Indexed keywords

GLUTATHIONE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ARTICLE; ASTROCYTE; BRAIN PERFUSION; CELL METABOLISM; CELL TRANSPORT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BRAIN; CELLS, CULTURED; CEREBROVASCULAR CIRCULATION; GLUTATHIONE; HUMANS; ORGANOTECHNETIUM COMPOUNDS; OXIDATION-REDUCTION; OXIMES; TECHNETIUM TC 99M EXAMETAZIME; TEMPERATURE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUMOR CELLS, CULTURED;

EID: 0029740239     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Neirinckx R, Canning LR, Piper IM, et al. Technetium-99m d,1-HMPAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 1987;28:191-202.
2. Podreka I, Suess E, Goldenberg G, et al. Initial experience with technetium-99m-HMPAO brain SPECT. J Nucl Med 1987;28:1657-1666.
3. 99mTc-d,1-HMPAO by rapid octanol extraction. J Cereb Blood Flow Metab 1988;8(suppl 1):S23-S30.
4. 99mTc-d,1-HMPAO in the human brain after intracarotid blus injection: a kinetic analysis. J Cereb Blood Flow Metab 1988;8(suppl 1):S13-S22.
5. Neirinckx R, Burke JF, Harrison RC, Forster AM, Andersen AR, Lassen NA. The retention mechanism of technetium-99m-HMPAO: intracellular reaction with glutathione. J Cereb Blood Flow Metab 1988;8:S4-S12.
6. 99mTc)-d,1-hexamethylpropylene amine oxime (HMPAO) compared with regional cerebral blood flow measured by PET: effect of linearization. J Cereb Blood Flow Metab 1988;8:S82-S89.
7. Gemmell HG, Evans NTS, Besson JAO, et al. Regional cerebral blood flow imaging: a quantitative comparison of technetium-99m-HMPAO SPECT with C-15 O2 PET. J Nucl Med 1990;31:1595-1600.
8. Murase K, Tanada S, Fujita Hea. Kinetic behavior of technetium-99m-HMPAO in the human brain and quantification of cerebral blood flow using dynamic SPECT. J Nucl Med 1992;33:135-143.
9. 99mTc-d,1-hexamethylpropyleneamine oxime (HMPAO) in patients with brain tumor studied by SPECT. Eur J Nucl Med 1986;14:39-44.
10. 99mTc-HMPAO in the study of brain tumors. Eur J Nucl Med 1988;14:39-44.
11. 201Tl SPECT). Nucl Med Commun 1993;14:1050-1060.
12. 99mTc-HMPAO. AJNR 1992;12:1187-1192.
13. Schmidbauer M, Podreka I, Wimberger D, Oder W, Koch Gea. SPECT and MR imaging in herpes simplex encephalitis. J Comput Assist Tomogr 1991;15:811-815.
14. 123IMP SPECT imaging during the subacute phase of stroke. Eur J Nucl Med 1990;16:17-22.
15. 99mTc-HMPAO SPECT. J Nucl Med 1994;35:1097-1103.
16. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980;106:207-212.
17. Moretti JL, Caglar M, Weinmann P. Cerebral perfusion imaging tracers for SPECT: which one to choose? J Nucl Med 1995;36:359-363.
18. 99mTc-HMPAO: basic kinetic studies of a tracer of cerebral blood flow. Cerebrovasc Brain Metab Rev 1989;1:288-318.